文献速递脑血管病认知障碍与痴呆

StrokeCog-15:慢性卒中后认知障碍的高效筛查简表

StrokeCog-15 Is an Efficient Neuropsychological Battery to Screen for Cognitive Impairment in Chronic Stroke.
PubMed 文献 · Stroke · 2025-05-23

本研究基于前瞻性观察队列 StrokeCog(n=126)开发了15分钟、4项测试的简表 StrokeCog-15,并在外部样本(n=61)中验证。该简表检测综合神经心理测验所识别的认知障碍敏感性高(推导样本0.97,验证样本0.93),特异性可接受(0.78、0.67),优于蒙特利尔认知评估和30分钟简表。

要点

  • StrokeCog-15 是15分钟、4项测试的简表,覆盖语言、记忆、工作记忆和处理速度/执行功能4个认知域。
  • 在推导样本中,StrokeCog-15 检测认知障碍的敏感性为0.97、特异性为0.78。
  • 在外部验证样本中,StrokeCog-15 的敏感性为0.93、特异性为0.67。

核心结论

  • 15分钟简表 StrokeCog-15 对综合神经心理测验所识别的慢性卒中后认知障碍具有高敏感性,是高效识别慢性卒中后认知障碍的手段。

研究设计与样本

  • 前瞻性观察队列 StrokeCog 验证样本126例慢性缺血性卒中患者(卒中后中位337天,IQR 235-1057)。
  • 综合认知测验耗时60分钟,含9项测试、覆盖5个认知域;采用偏最小二乘回归分析筛选出15分钟4项测试的 StrokeCog-15。
  • 在平行研究 Stroke-IMPaCT 的外部验证样本61例(卒中后中位210天,IQR 193-230)中评估 StrokeCog-15 的效用。

主要发现

  • 认知障碍常见:两个队列中分别有50%(n=61)和66%(n=40)存在认知障碍。
  • 缺陷最常出现在记忆和处理速度/执行功能域。
  • 推导样本中,StrokeCog-15 敏感性0.97、特异性0.78,优于蒙特利尔认知评估(敏感性0.77、特异性0.73)和30分钟简表(敏感性0.97、特异性0.35)。
  • 验证样本中,StrokeCog-15 敏感性0.93、特异性0.67。

关键数值与推荐

  • StrokeCog-15 含4项测试,耗时15分钟,覆盖语言、记忆、工作记忆、处理速度/执行功能4个认知域。
  • 综合认知测验耗时60分钟,含9项测试、覆盖5个认知域,作为认知障碍的参照标准。
  • 推导样本中 StrokeCog-15 敏感性0.97、特异性0.78;蒙特利尔认知评估敏感性0.77、特异性0.73;30分钟简表敏感性0.97、特异性0.35。
  • 验证样本中 StrokeCog-15 敏感性0.93、特异性0.67。

临床怎么用

  • StrokeCog-15 可作为慢性卒中后认知障碍的高效筛查工具,覆盖卒中常影响的多个认知域。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poststroke cognitive impairment can significantly impact functional outcomes and quality of life. While comprehensive neuropsychological evaluations are valuable in characterizing this impairment, their time-intensive nature is not always feasible. Thus, we set out to develop a brief cognitive battery that is sensitive to poststroke cognitive impairment. METHODS: Neuropsychological testing was completed in a validation sample of 126 participants with chronic ischemic stroke (median days since stroke, 337 [interquartile range, 235-1057]) as part of StrokeCog, a prospective observational cohort study. This comprehensive 60-minute cognitive battery contained 9 tests covering 5 cognitive domains. A partial least square regression analysis informed the selection of a brief, 15-minute battery of 4 tests (StrokeCog-15) covering 4 cognitive domains: language, memory, working memory, and processing speed/executive functioning. We then compared StrokeCog-15 with Montreal Cognitive Assessment and an established 30-minute battery in its ability to detect cognitive impairment as identified by the comprehensive battery. Finally, we assessed the utility of StrokeCog-15 in an external validation sample of 61 participants (median days since stroke, 210 [interquartile range, 193-230]) enrolled in the parallel Stroke-IMPaCT study (Stroke-Immune Mediated Pathways and Cognitive Trajectory). RESULTS: Cognitive impairment was common, occurring in 50% (n=61) and 66% (n=40) of the 2 cohorts. Deficits occurred most frequently in the memory and processing speed/executive functioning domains. In the derivation sample, StrokeCog-15 demonstrated high sensitivity (0.97) and adequate specificity (0.78) in detecting cognitive impairment on the comprehensive battery, outperforming both Montreal Cognitive Assessment (sensitivity, 0.77; specificity, 0.73) and the 30-minute battery (sensitivity, 0.97; specificity, 0.35). StrokeCog-15 similarly demonstrated high sensitivity (0.93) and adequate specificity (0.67) in the validation sample. CONCLUSIONS: A brief 15-minute battery of tests has high sensitivity to detect cognitive impairment as identified on a longer neuropsychological test battery. StrokeCog-15 assesses multiple cognitive domains commonly impacted by stroke and represents an efficient yet effective means to identify chronic poststroke cognitive impairment.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Drag LL, Mlynash M, Aslan A, et al. StrokeCog-15 Is an Efficient Neuropsychological Battery to Screen for Cognitive Impairment in Chronic Stroke. Stroke. 2025. PMID: 40406877. doi:10.1161/STROKEAHA.124.049217

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。